BioNexus Gene Lab Corp 10-Q filing
Filed 2025-08-18 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001477932-25-006023
- Form type
- 10-Q
- CIK
- 0001737523
- Primary document
- https://www.sec.gov/Archives/edgar/data/1737523/000147793225006023/bglc_10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BioNexus Gene Lab Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $4.4M | - | - |
| Cost Of Revenue | $3.7M | - | - |
| Gross Profit | $711,515 | - | - |
| Operating Income | $-1.2M | - | - |
| Net Income | $-1.2M | - | - |
| Eps Diluted | -0.69 | - | - |
| Total Assets | $9.4M | - | - |
| Total Liabilities | $1.9M | - | - |
| Shareholders Equity | $7.5M | - | - |
| Operating Cash Flow | $-1.6M | - | - |
| Capital Expenditures | $30,511 | - | - |